Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up

Urology. 2001 Feb;57(2):225-9. doi: 10.1016/s0090-4295(00)00994-8.
No abstract available

Publication types

  • Review

MeSH terms

  • Bone and Bones / diagnostic imaging
  • Cryotherapy
  • Disease-Free Survival
  • Follow-Up Studies
  • Humans
  • Lymph Node Excision
  • Magnetic Resonance Imaging
  • Male
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local / diagnosis
  • Neoplasm Staging / methods*
  • Pelvis
  • Prostate-Specific Antigen / blood*
  • Prostatectomy
  • Prostatic Neoplasms / pathology*
  • Prostatic Neoplasms / radiotherapy
  • Prostatic Neoplasms / therapy
  • Radionuclide Imaging
  • Tomography, X-Ray Computed

Substances

  • Prostate-Specific Antigen